| Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? JL Bell, K Wächter, B Mühleck, N Pazaitis, M Köhn, M Lederer, ... Cellular and molecular life sciences 70, 2657-2675, 2013 | 877 | 2013 |
| The critical role of RNA m6A methylation in cancer Q Lan, PY Liu, J Haase, JL Bell, S Hüttelmaier, T Liu Cancer research 79 (7), 1285-1292, 2019 | 628 | 2019 |
| The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance Q Lan, PY Liu, JL Bell, JY Wang, S Hüttelmaier, XD Zhang, L Zhang, T Liu Cancer research 81 (13), 3431-3440, 2021 | 177 | 2021 |
| IGF2BP1 Harbors Prognostic Significance by Gene Gain and Diverse Expression in Neuroblastoma JL Bell, R Turlapati, T Liu, JH Schulte, S Hüttelmaier Journal of Clinical Oncology 33 (11), 1285-1293, 2015 | 174 | 2015 |
| Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression PY Liu, D Erriquez, GM Marshall, AE Tee, P Polly, M Wong, B Liu, JL Bell, ... JNCI: Journal of the National Cancer Institute 106 (7), dju113, 2014 | 127 | 2014 |
| WDR5 supports an N-Myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma Y Sun, JL Bell, D Carter, S Gherardi, RC Poulos, G Milazzo, JWH Wong, ... Cancer research 75 (23), 5143-5154, 2015 | 122 | 2015 |
| TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members JL Bell, A Malyukova, JK Holien, J Koach, MW Parker, M Kavallaris, ... PloS one 7 (5), e37470, 2012 | 120 | 2012 |
| The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription M Wong, AEL Tee, G Milazzo, JL Bell, RC Poulos, B Atmadibrata, Y Sun, ... Cancer research 77 (9), 2522-2533, 2017 | 84 | 2017 |
| JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma M Wong, Y Sun, Z Xi, G Milazzo, RC Poulos, C Bartenhagen, JL Bell, ... Nature Communications 10 (1), 3319, 2019 | 80 | 2019 |
| TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells GM Marshall, JL Bell, J Koach, O Tan, P Kim, A Malyukova, W Thomas, ... Oncogene 29 (46), 6172-6183, 2010 | 76 | 2010 |
| TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization JL Bell, A Malyukova, M Kavallaris, GM Marshall, BB Cheung Cell cycle 12 (6), 889-898, 2013 | 58 | 2013 |
| The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation A Raif, GM Marshall, JL Bell, J Koach, O Tan, C D’andreti, W Thomas, ... Cancer letters 277 (1), 82-90, 2009 | 46 | 2009 |
| The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro BB Cheung, J Koach, O Tan, P Kim, JL Bell, C D'andreti, S Sutton, ... The Journal of pathology 226 (3), 451-462, 2012 | 43 | 2012 |
| IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis J Haase, D Misiak, M Bauer, N Pazaitis, J Braun, R Pötschke, A Mensch, ... Modern Pathology 34 (1), 32-41, 2021 | 37 | 2021 |
| The estrogen-responsive B box protein is a novel regulator of the retinoid signal BB Cheung, J Bell, A Raif, A Bohlken, J Yan, B Roediger, A Poljak, ... Journal of Biological Chemistry 281 (26), 18246-18256, 2006 | 37 | 2006 |
| Drugging MYCN oncogenic signaling through the MYCN-PA2G4 binding interface J Koach, JK Holien, H Massudi, DR Carter, OC Ciampa, M Herath, T Lim, ... Cancer research 79 (21), 5652-5667, 2019 | 32 | 2019 |
| IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression S Hagemann, D Misiak, JL Bell, T Fuchs, MI Lederer, N Bley, M Hämmerle, ... Molecular Cancer 22 (1), 88, 2023 | 27 | 2023 |
| ATP7A is a novel target of retinoic acid receptor β2 in neuroblastoma cells A Bohlken, BB Cheung, JL Bell, J Koach, S Smith, E Sekyere, W Thomas, ... British journal of cancer 100 (1), 96-105, 2009 | 27 | 2009 |
| The MicroRNA landscape of MYCN-amplified neuroblastoma D Misiak, S Hagemann, JL Bell, B Busch, M Lederer, N Bley, JH Schulte, ... Frontiers in Oncology 11, 647737, 2021 | 25 | 2021 |
| Identification of RNA-binding proteins as targetable putative oncogenes in neuroblastoma JL Bell, S Hagemann, JK Holien, T Liu, Z Nagy, JH Schulte, D Misiak, ... International Journal of Molecular Sciences 21 (14), 5098, 2020 | 22 | 2020 |
Stefan Hüttelmaier (PhD)Martin Luther University Halle-WittenbergVerified email at medizin.uni-halle.de